Study of a new lung treatment for people with COPD
Part of Lungs & breathing clinical trials.
This trial tests a device called dNerva that targets nerves in the lungs to help people with COPD breathe easier. It is designed for those who have moderate to severe COPD and are not currently smoking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have a history of smoking at least 10 pack-years (e.g., 1 pack a day for 10 years).
- You have not smoked or used any inhaled substances (including vaping or cannabis) for at least 2 months and agree to stay smoke-free during the study.
- You have moderate to severe COPD confirmed by breathing tests, and you are on daily inhaled medications.
- You are willing to undergo a bronchoscopy (a scope through the mouth to the lungs) and follow all study procedures, including taking extra medications like prednisone and azithromycin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special radiofrequency treatment delivered through a bronchoscope (a thin camera tube) is safe and works better than standard care for people with COPD. It focuses on people with moderate-to-severe COPD symptoms who can follow study visits and tests.
This trial tests a new bronchoscopy treatment for people with chronic obstructive pulmonary disease (COPD) who have had flare-ups. It aims to find if this treatment can help reduce symptoms and improve quality of life.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
This trial tests a portable “positive pressure” breathing device in people with severe COPD to see how well it works and whether it’s safe. It may help if you have trouble breathing and meet the device and health requirements.
This trial tests a new drug called AZD6793 for people with moderate to very severe COPD. It aims to see if the drug can help improve breathing and reduce flare-ups.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.